Phase I clinical and pharmacokinetic study of combination chemotherapy with topotecan and ifosfamide in patients with progressive or relapsed solid tumors.

被引:0
|
作者
C.-P. Schneider
U. Merkel
U. Grübner
R. Kath
K. Höffken
A. Hoffmann
机构
[1] Department of Internal Medicine II (Hematology,
[2] Oncology,undefined
[3] Endocrinology and Metabolic Diseases),undefined
[4] Friedrich-Schiller University Jena,undefined
[5] Erlanger Allee 101,undefined
[6] 07740 Jena,undefined
[7] Germany ,undefined
[8] Institute for Clinical Pharmacology,undefined
[9] Friedrich-Schiller University Jena,undefined
[10] Jena,undefined
[11] Germany,undefined
来源
Journal of Cancer Research and Clinical Oncology | 2002年 / 128卷
关键词
Topotecan Ifosfamide Solid tumor Chemotherapy Refractory cancer;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:313 / 318
页数:5
相关论文
共 50 条
  • [1] Phase I clinical and pharmacokinetic study of combination chemotherapy with topotecan and ifosfamide in patients with progressive or relapsed solid tumors
    Schneider, CP
    Merkel, U
    Grübner, U
    Kath, R
    Höffken, K
    Hoffmann, A
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2002, 128 (06) : 313 - 318
  • [2] A phase I study of simvastatin in combination with topotecan and cyclophosphamide in pediatric patients with relapsed and/or refractory solid and CNS tumors.
    Cash, Thomas
    Jonus, Hunter C.
    Tsvetkova, Maya
    Beumer, Jan Hendrik
    Lee, Jasmine Y.
    Henry, Curtis
    Aguilera, Dolly
    Harvey, R. Donald
    Goldsmith, Kelly C.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [3] Phase I clinical and pharmacokinetic study of irofulven in combination with oxaliplatin in patients with advanced solid tumors.
    Alexandre, J
    Tchen, N
    Berthault-Cvitkovic, F
    Misset, JL
    Benettaib, B
    Kahatt, C
    Raymond, E
    Weems, G
    MacDonald, JR
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9057S - 9057S
  • [4] Pemetrexed in combination with paclitaxel: A phase I clinical and pharmacokinetic trial in patients with solid tumors.
    Graefe, T.
    Bolling, C.
    Lubbing, C.
    Latz, J.
    Blatter, J.
    Hanauske, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 91S - 91S
  • [5] Topotecan and Ifosfamide Therapy for Pediatric Patients with Relapsed Solid Tumors
    Sugiyama, M.
    Arakawa, A.
    Shirakawa, N.
    Tomoko, S.
    Nakajima, M.
    Ishimaru, S.
    Kumamoto, T.
    Kawakubo, N.
    Hishiki, T.
    Kawai, A.
    Ogawa, C.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S336 - S336
  • [6] Phase I and pharmacokinetic study of farletuzumab in solid tumors.
    Sasaki, Yasutsuna
    Miwa, Keisuke
    Yamashita, Keishi
    Fujiwara, Keiichi
    Katsumata, Noriyuki
    Fujiwara, Yasuhiro
    Namiki, Masayuki
    Koyanagi, Nozomu
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [7] A phase I study of Lapatinib (GW572016) and topotecan in patients with solid tumors.
    Erlichman, C
    Adjei, AA
    Joy, ME
    Rubin, SD
    Friedman, RA
    Ames, MM
    Reid, JM
    Molina, JR
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 8994S - 8994S
  • [8] Phase I pharmacokinetic (PK) study of daily imatinib in combination with docetaxel for patients with advanced solid tumors.
    Chatta, GS
    Fakih, M
    Ramalingam, S
    Belani, CP
    Ramanathan, RK
    Zamboni, N
    Friedland, D
    Lis, D
    Tutchko, S
    Egorin, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 138S - 138S
  • [9] Combination Chemotherapy of Vinorelbine and Cisplatin: A Phase I Pharmacokinetic Study in Patients with Metastatic Solid Tumors
    Delord, Jean-Pierre
    Puozzo, Christian
    Lefresne, Florence
    Bugat, Roland
    ANTICANCER RESEARCH, 2009, 29 (02) : 553 - 560
  • [10] Pharmacokinetic and pharmacodynamic study of the combination of docetaxel and topotecan in patients with solid tumors
    Zamboni, WC
    Egorin, MJ
    Van Echo, DA
    Day, RS
    Meisenberg, BR
    Brooks, SE
    Doyle, LA
    Nemieboka, NN
    Dobson, JM
    Tait, NS
    Tkaczuk, KH
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (18) : 3288 - 3294